Inspectors at the US Food and Drug Administration (FDA) say lack of data integrity, transparency, record retention, and inadequate controls are some of the most common issues they see during inspections of manufacturers, according to a US Food and Drug Administration (FDA) official who spoke at the Orange County Regulatory Affairs Discussion Group annual conference...[RAPS]
